A detailed history of Sunpointe, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sunpointe, LLC holds 5,358 shares of BMY stock, worth $308,513. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,358
Previous 5,111 4.83%
Holding current value
$308,513
Previous $212 Million 30.61%
% of portfolio
0.23%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$39.66 - $51.75 $9,796 - $12,782
247 Added 4.83%
5,358 $277 Million
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $38,358 - $50,499
953 Added 22.92%
5,111 $212 Million
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $199,500 - $226,195
4,158 New
4,158 $225 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.